Teeft.i
Checkpoint
Istex
Racine
Checkpoint
Istex
Exploration
Accueil
Racine
Racine

Serveur d'exploration H2N2 - Checkpoint (Istex)

Index « Teeft.i » - entrée « Vaccine development »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Vaccine design < Vaccine development < Vaccine developments  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 20.
Ident.Authors (with country if any)Title
000246 (2010) Doris Bucher [États-Unis] ; Terrence Tumpey [Géorgie (pays)] ; Anice Lowen [États-Unis] ; James Gill [États-Unis] ; Michael Shaw [Géorgie (pays)] ; James Matthews ; Jose Galarza [États-Unis] ; Jennifer Minieri Arroyo [États-Unis] ; Philip Ralph Dormitzer [États-Unis]2009 H1N1 swine flu: the 2010 perspective
000409 (2007) Landis Mackellar [Autriche]Pandemic Influenza: A Review
000418 (2007) George DehnerFlu: Past and Present
000485 (2006) Alan W. Hampson [Australie]Avian influenza: A pandemic waiting in the wings?
000671 (2001) J. M. Wood [Royaume-Uni] ; K. G. Nicholson [Royaume-Uni] ; M. Zambon [Royaume-Uni] ; R. Hinton [Royaume-Uni] ; D. L. Major [Royaume-Uni] ; R. W. Newman [Royaume-Uni] ; U. Dunleavy [Royaume-Uni] ; D. Melzack [Royaume-Uni] ; J. S. Robertson [Royaume-Uni] ; G. C. Schild [Royaume-Uni]Developing vaccines against potential pandemic influenza viruses
000711 (2001) Alexander C. Schmidt [États-Unis] ; Robert B. Couch [États-Unis] ; George J. Galasso [États-Unis] ; Frederick G. Hayden [États-Unis] ; John Mills [Australie] ; Brian R. Murphy [États-Unis] ; Robert M. Chanock [États-Unis]Current research on respiratory viral infections: Third International Symposium
000781 (1999) Frank Shann [Australie] ; Mark C. Steinhoff [États-Unis]Vaccines for children in rich and poor countries
000820 (1999) Maurice R. Hilleman [États-Unis]Personal historical chronicle of six decades of basic and applied research in virology, immunology, and vaccinology
000845 (1998) Karl G. Nicholson ; Jonathan S. Nguyen-Van-Tam ; Ala'Eldin H. Ahmed ; Martin J. Wiselka ; Jane Leese [Royaume-Uni] ; Jon Ayres [Royaume-Uni] ; James H. Campbell ; Philip Ebden ; Noemi M. Eiser [Royaume-Uni] ; Bruce J. Hutchcroft ; James Cg Pearson ; Richard F. Willey ; Roger J. Wolstenholme ; Mark A. Woodhead [Royaume-Uni]Randomised placebo-controlled crossover trial on effect of inactivated influenza vaccine on pulmonary function in asthma
000931 (1997) Pierre Vialat [France] ; Rolf Muller [France] ; Thuy Hang Vu [France] ; Christophe Prehaud [France] ; Michèle Bouloy [France]Mapping of the mutations present in the genome of the Rift Valley fever virus attenuated MP12 strain and their putative role in attenuation
000987 (1996) Raphael Levi [Israël] ; Ruth Arnon [Israël]Synthetic recombinant influenza vaccine induces efficient long-term immunity and cross-strain protection
000A52 (1996) Gordon AdaDo cytotoxic T lymphocytes clear some HIV/SIV infections?
000C12 (1994) Harumi Kuno-Sakai [Japon] ; Mikio Kimura [Japon] ; Kazuyo Ohta [Japon] ; Rumi Shimojima [Japon] ; Yasumasa Oh [Japon] ; Hideo Fukumi [Japon]Developments in mucosal influenza virus vaccines
000C14 (1994) C. W. Potter [Royaume-Uni]Attenuated influenza virus vaccines
000E04 (1990) Then as Now
000E10 (1990) F. Shann [Australie]Pneumococcus and influenza
000E40 (1990) Kenneth M. Mcconnochie [États-Unis] ; Caroline B. Hall [États-Unis] ; Edward E. Walsh [États-Unis] ; Klaus J. Roghmann [États-Unis]Variation in severity of respiratory syncytial virus infections with subtype
000F77 (1988) Robert F. Betts [États-Unis] ; R. Gordon Douglas ; Hunien F. Maassab Jr. ; Dan C. Deborde ; Mary Lou Clements [États-Unis] ; Brian R. MurphyAnalysis of virus and host factors in a study of A/Peking/2/79 (H3N2) cold‐adapted vaccine recombinant in which vaccine‐associated illness occurred in normal volunteers
001196 (1984) F. A. I. Riordan [Royaume-Uni] ; K. Wakelin [Royaume-Uni] ; P. J. Wood [Royaume-Uni] ; P. Betts [Royaume-Uni] ; B. E. Clayton [Royaume-Uni]BLOODSPOT 17α-HYDROXYPROGESTERONE RADIOIMMUNOASSAY FOR DIAGNOSIS OF CONGENITAL ADRENAL HYPERPLASIA AND HOME MONITORING OF CORTICOSTEROID REPLACEMENT THERAPY
001203 (1984) Marylou Clements [États-Unis] ; Robertf Betts [États-Unis] ; Brianr Murphy [États-Unis]ADVANTAGE OF LIVE ATTENUATED COLD-ADAPTED INFLUENZA A VIRUS OVER INACTIVATED VACCINE FOR A/WASHINGTON/80 (H3N2) WILD-TYPE VIRUS INFECTION

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/Istex/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/Teeft.i -k "Vaccine development" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/Teeft.i  \
                -Sk "Vaccine development" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Checkpoint/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    H2N2V1
   |flux=    Istex
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Teeft.i
   |clé=    Vaccine development
}}
Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 14 19:59:40 2020. Site generation: Thu Mar 25 15:38:26 2021